Adaptive Biotechnologies' Grant - II Round

Adaptive Biotechnologies raised a round of funding on September 13, 2013. Investors include National Institutes of Health.

Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…

Articles about Adaptive Biotechnologies' Grant - II Round: